European regulators have given Biocartis CE mark approval for its Idylla EGFR Mutation Test for lung cancer. The PCR-based test, which requires hands-on time of less than two minutes, directly detects 51 EGFR mutations from a slice of FFPE tissue and produces results in 2.5 hours.
Biocartis' EGFR mutation test wins EU approval
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.